Cargando…
From Biologics to Biosimilars and Biobetters – Democratization of High-end Therapeutics
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933873/ https://www.ncbi.nlm.nih.gov/pubmed/33463558 http://dx.doi.org/10.4103/ijo.IJO_150_21 |